The JDRF Greater New England chapter is delighted to welcome its newly-elected community board members beginning July 1. The Board of Directors is committed to serving as champions for JDRF’s vision and mission—accelerating the development of cures and to create new treatments and technologies to keep people with type 1 diabetes (T1D) as healthy as possible until we do. They play a pivotal role in cultivating meaningful connections for JDRF that proactively drive fundraising to fulfill JDRF’s mission. Please welcome: 

Noah Gardner
Senior Director, Intellia Therapeutics
“I was diagnosed with T1D in February 1994 at the age of 11. Growing up in the small town of Princeton, MA there weren’t a lot of local resources outside of one family friend. JDRF was that first ray of hope in allowing us to feel like we could make a difference in accelerating a cure by fundraising through what is now the JDRF One Walk. I have personally benefited from the technology and medical advancements that JDRF has helped to fund over the last 29 years. As a scientist working to help cure others of disease, it is my honor to help JDRF move forward to help the community that I most identify with.”

Jaleen Siekman
Professional background in government relations – federal and state regulatory policy and international trade policy
“I am honored to be serving as the President of the Greater New England Community Board. Since our family first engaged with JDRF, its staff and volunteers have welcomed us, provided hope and inspiration, and empowered us to make an impact. I look forward to partnering with our JDRF community to continue to strengthen our existing programs. Offering more families, individuals, and companies in Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont opportunities to engage with JDRF continues to be a priority. The energy, passion, and determination of the entire T1D community is essential to our shared mission to accelerate life changing breakthroughs to cure, prevent, and treat T1D and its complications.”